← All companies
COCH
Envoy Medical, Inc.
$0.69
+0.02 +2.91%
Key statistics
from XBRL data in SEC filingsMarket cap
$53.1M
Revenue (TTM)
$234K
Net income (TTM)
-$23.1M
EPS (TTM)
$-1.02
P/E ratio
—
Dividend yield
—
Free cash flow
-$18.4M
Cash
$25.3M
Total assets
$29.8M
Gross margin
—
52-week range
$0.36 – $1.89
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Terminated a material agreement
Jun 30, 2026
8-K
Director or officer change
Jun 25, 2026
8-K
Delisting notice or listing-rule failure
May 22, 2026
8-K
Director or officer change; Shareholder vote results
May 18, 2026
10-Q
Quarter ended 2026-03-31
May 11, 2026
8-K
Results of operations (earnings release)
May 11, 2026
8-K
Director or officer change
Apr 21, 2026
10-K/A
Fiscal year ended 2025-12-31
Apr 13, 2026
8-K
Changed accountants
Mar 31, 2026
8-K
Results of operations (earnings release)
Mar 27, 2026
10-K
Fiscal year ended 2025-12-31
Mar 23, 2026
8-K
Delisting notice or listing-rule failure; Other events
Feb 27, 2026
8-K
Entered a material agreement; Other events
Feb 13, 2026
8-K
Director or officer change
Feb 11, 2026
8-K
Entered a material agreement
Dec 29, 2025
8-K
Regulation FD disclosure
Dec 16, 2025
8-K
Shareholder vote results
Dec 3, 2025
8-K
Delisting notice or listing-rule failure
Nov 25, 2025
10-Q
Quarter ended 2025-09-30
Nov 10, 2025
8-K
Results of operations (earnings release)
Nov 10, 2025
8-K
Delisting notice or listing-rule failure; Other events
Oct 28, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Other events
Oct 9, 2025
8-K
Other events
Oct 7, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Other events
Sep 23, 2025
8-K
Other events
Sep 19, 2025
8-K
Entered a material agreement
Sep 9, 2025
8-K
Delisting notice or listing-rule failure
Aug 29, 2025
8-K
Terminated a material agreement; Director or officer change
Aug 26, 2025
10-Q
Quarter ended 2025-06-30
Jul 31, 2025
8-K
Results of operations (earnings release)
Jul 31, 2025
8-K
Entered a material agreement
Jul 29, 2025
8-K
Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity
Jul 2, 2025
8-K
Director or officer change
Jun 25, 2025
8-K
Director or officer change; Shareholder vote results
Jun 3, 2025
8-K
Director or officer change
May 19, 2025
8-K
Results of operations (earnings release)
May 1, 2025
10-Q
Quarter ended 2025-03-31
May 1, 2025
8-K
Item 5.08
Apr 11, 2025
8-K
Results of operations (earnings release)
Mar 31, 2025
10-K
Fiscal year ended 2024-12-31
Mar 31, 2025